Cancer Treatment Reviews
Volume 37, Issue 2 , Pages 97-104 , April 2011

Which factors should be taken into account in perimenopausal women with early breast cancer who may become eligible for an aromatase inhibitor? Recommendations of an expert panel

  • O. Ortmann

      Affiliations

    • Department of Gynaecology and Obstetrics, University of Regensburg, Germany
    • Corresponding Author InformationCorresponding author. Address: Department of Gynaecology and Obstetrics, University of Regensburg, Landshuter Strasse 65, D-93053 Regensburg, Germany. Tel.: +49 941 782 7511; fax: +49 941 782 7515.
    • ,
  • O. Pagani

      Affiliations

    • Institute of Oncology of Southern Switzerland, Bellinzona, Switzerland
    • ,
  • A. Jones

      Affiliations

    • Department of Clinical Oncology, Royal Free Hospital, London, UK
    • ,
  • N. Maass

      Affiliations

    • University Clinic for Gynaecology and Obstetrics, Aachen, Germany
    • ,
  • D. Noss

      Affiliations

    • Department of Gynaecology and Obstetrics, University of Regensburg, Germany
    • ,
  • H. Rugo

      Affiliations

    • University of California San Francisco Comprehensive Cancer Center, San Francisco, CA, USA
    • ,
  • C. van de Velde

      Affiliations

    • Department of Surgery, Leiden University Medical Centre, Leiden, The Netherlands
    • ,
  • Matti Aapro

      Affiliations

    • Clinique de Genolier, Genolier, Switzerland
    • ,
  • R. Coleman

      Affiliations

    • Academic Unit of Clinical Oncology, Weston Park Hospital, Sheffield, UK

Received 24 March 2010 ,Revised 21 May 2010 ,Accepted 25 May 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0305-7372(10)00104-0

doi: 10.1016/j.ctrv.2010.05.005

Cancer Treatment Reviews
Volume 37, Issue 2 , Pages 97-104 , April 2011

Article Tools

* Image Usage & Resolution